Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
NextCure, Inc. (NXTC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| Mayer Timothy (COO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 03/01/2023 |
4
| Kundu Sourav (Sr VP, Dev. & Mfg.) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.55, valued at
$116.3k
|
|
| 03/01/2023 |
4
| Myint Han (Chief Medical Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 03/01/2023 |
4
| Shaw Kevin G. (Sr VP, Legal Affairs) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.55, valued at
$116.3k
|
|
| 03/01/2023 |
4
| Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 03/01/2023 |
4
| Richman Michael (President & CEO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 309,000 options to buy
@ $1.55, valued at
$479k
|
|
| 03/01/2023 |
4
| Cobourn Steven P. (CFO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.55, valued at
$209.3k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Borgman Anne Elizabeth (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $4.77, valued at
$68k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Feigal Ellen (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 28,500 options to buy
@ $7.56, valued at
$215.5k
Granted 10,384 options to buy
@ $7.56, valued at
$78.5k
|
|
| 10/05/2021 |
4
| Borgman Anne Elizabeth (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 28,500 options to buy
@ $7.56, valued at
$215.5k
Granted 10,384 options to buy
@ $7.56, valued at
$78.5k
|
|
| 07/19/2021 |
4
| Kundu Sourav (Sr VP, Dev. & Mfg.) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 150,000 options to buy
@ $7.89, valued at
$1.2M
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Mayer Timothy (COO) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 100,000 options to buy
@ $12.59, valued at
$1.3M
|
|
|
|
|